Patents by Inventor Pilar SANCHÍS CORTÉS

Pilar SANCHÍS CORTÉS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USE OF PHYTIC ACID OR THE SALTS THEREOF, ALONE OR COMBINED WITH B6 VITAMERS, FOR PREVENTING THE FORMATION OF ADVANCED GLYCATION END-PRODUCT
    Publication number: 20180214463
    Abstract: The invention relates to the use of phytate or any of the salts thereof for preventing the formation of advanced glycation end-products (AGE), toxic products that are produced in pathologies such as diabetes, either alone or combined with B6 vitamins such as pyridoxamine and forming part of a medicament or a pharmaceutical composition produced so as to be administered via oral, rectal, subcutaneous, intra-arterial, intramuscular, intraspinal, intracranial, intravenous or inhalation routes.
    Type: Application
    Filed: July 8, 2016
    Publication date: August 2, 2018
    Inventors: Félix GRASES FREIXEDAS, Antonia COSTA BAUZÁ, Miguel ADROVER ESTELRICH, Francisco BERGA MONTANER, Pilar SANCHÍS CORTÉS, Luis MASMIQUEL COMAS, Rosmeri RIVERA IROGOIN, Regina FORTUNY MARQUÉS
  • Fixed-dose association of phytate and zinc
    Patent number: 9144578
    Abstract: The invention relates to a fixed-dose association of phytate and zinc in synergic proportions for use in the treatment of crystallization of hydroxyapatite. Advantageously, said association is in a molar ratio between the phytate and the zinc exceeding 4:1. The invention also relates to the use of said association for manufacturing a drug for the treatment, prophylaxis and/or prevention crystallization of hydroxyapatite in humans.
    Type: Grant
    Filed: February 19, 2013
    Date of Patent: September 29, 2015
    Assignee: Universitat de les Illes Balears
    Inventors: Felix Grases Freixedas, Joan Perello Bestard, Bernat Isern Amengual, Pilar Sanchis Cortes, Rafael M. Prieto Almirall, Antonia Costa Bauza
  • Use of phytate as agent inhibiting dissolution of crystals of calcium salts for the prevention of osteoporosis
    Patent number: 8377909
    Abstract: The present invention relates to the use of myo-inositol hexaphosphate or a pharmaceutically acceptable salt thereof for the manufacture of a medicament for the prevention or treatment of a disease associated with the dissolution of crystals of calcium salts, in particular osteoporosis. These compounds may be utilized in the manufacture of functional foods, dietetic supplements, vitamin supplements, nutritional supplements, food supplements, or phytotherapeutic products having properties of inhibition of dissolution of crystals of calcium salts.
    Type: Grant
    Filed: May 30, 2007
    Date of Patent: February 19, 2013
    Assignee: Universitat de les Illes Balears
    Inventors: Felix Grases Freixedas, Pilar Sanchis Cortes, Antonia Costa-Bauza, Joan Perello Bestard, Rafael Mara Prieto Almirall, Bernat Isern Amengual, Ramon Garcia Gonzalez
  • Fixed-dose association of phytate and zinc
    Patent number: 8377908
    Abstract: The invention relates to a fixed-dose association of 5 phytate and zinc in synergic proportions for use in the treatment of crystallization of hydroxyapatite. Advantageously, said association is in a molar ratio between the phytate and the zinc exceeding 4:1. The invention also relates to the use of said 10 association for manufacturing a drug for the treatment, prophylaxis and/or prevention crystallization of hydroxyapatite in humans.
    Type: Grant
    Filed: February 14, 2007
    Date of Patent: February 19, 2013
    Inventors: Felix Grases Freixedas, Joan Perello Bestard, Bernat Isern Amengual, Pilar Sanchis Cortes, Rafael M Prieto Almirall, Antonia Costa Bauza
  • USE OF PHYTATE AS AGENT INHIBITING DISSOLUTION OF CRYSTALS OF CALCIUM SALTS FOR THE PREVENTION OF OSTEOPOROSIS
    Publication number: 20090203650
    Abstract: The present invention relates to the use of myo-inositol hexaphosphate or a pharmaceutically acceptable salt thereof for the manufacture of a medicament for the prevention or treatment of a disease associated with the dissolution of crystals of calcium salts, in particular osteoporosis. These compounds may be utilized in the manufacture of functional foods, dietetic supplements, vitamin supplements, nutritional supplements, food supplements, or phytotherapeutic products having properties of inhibition of dissolution of crystals of calcium salts.
    Type: Application
    Filed: May 30, 2007
    Publication date: August 13, 2009
    Applicant: UNIVERSITAT DE LES ILLES BALEARS
    Inventors: Felix Grases Freixedas, Pilar Sanchis Cortes, Antonia Costa-Bauza, Joan Perello Bestard, Rafael Mara Prieto Almirall, Bernat Isern Amengual, Ramon Garcia Gonzalez
  • FIXED-DOSE ASSOCIATION OF PHYTATE AND ZINC
    Publication number: 20090035232
    Abstract: The invention relates to a fixed-dose association of 5 phytate and zinc in synergic proportions for use in the treatment of crystallisation of hydroxyapatite. Advantageously, said association is in a molar ratio between the phytate and the zinc exceeding 4:1. The invention also relates to the use of said 10 association for manufacturing a drug for the treatment, prophylaxis and/or prevention crystallisation of hydroxyapatite in humans.
    Type: Application
    Filed: February 14, 2007
    Publication date: February 5, 2009
    Applicant: UNIVERSITAT DE LES ILLES BALEARS
    Inventors: Felix Grases Freixedas, Joan Perello Bestard, Bernat Isern Amengual, Pilar Sanchis Cortes, Rafael M. Prieto Almirall, Antonia Costa Bauza